心血管康复医学杂志
心血管康複醫學雜誌
심혈관강복의학잡지
JOURNAL OF CARDIOVASCULAR REHABILITATION MEDICINE
2015年
3期
319-322
,共4页
高血压%心律失常 ,心性%西拉普利
高血壓%心律失常 ,心性%西拉普利
고혈압%심률실상 ,심성%서랍보리
Hypertension%Arrhythmias,cardiac%Cilazapri
目的:研究西拉普利与氨氯地平对原发性高血压患者QT间期离散度与心律失常的疗效。方法:2011年3月~2014年3月我院收治的120例原发性高血压合并室性心律失常的患者被纳入研究对象,随机均分为西拉普利组和氨氯地平组,两组均接受常规降压治疗,比较两组的血压、QT间期以及心律失常情况。结果:与氨氯地平组比较,西拉普利组患者的24h平均收缩压[(123.81±17.95) mmHg比(104.92±14.25) mmHg]、舒张压[(88.31±10.28) mm-Hg比(72.24±8.45) mmHg],24h平均收缩压变异度[(11.62±1.34) mmHg比(7.34±0.97) mmHg]、舒张压变异度[(9.47±1.18) mmHg比(5.13±0.72) mmHg],QT间期[(385.1±50.4) ms比(342.7±48.5) ms]、校正QT间期[(362.7±50.2) ms比(321.8±45.1) ms]、QT间期离散度[(34.1±5.1) ms比(22.5±3.7) ms]均明显降低(P<0.05或<0.01);室性心律失常分级明显优于氨氯地平组(P<0.05)。结论:对于高血压并发心律失常病人西拉普利治疗较氨氯地平降低血压,QT间期离散度和改善室性心律失常的疗效更好。
目的:研究西拉普利與氨氯地平對原髮性高血壓患者QT間期離散度與心律失常的療效。方法:2011年3月~2014年3月我院收治的120例原髮性高血壓閤併室性心律失常的患者被納入研究對象,隨機均分為西拉普利組和氨氯地平組,兩組均接受常規降壓治療,比較兩組的血壓、QT間期以及心律失常情況。結果:與氨氯地平組比較,西拉普利組患者的24h平均收縮壓[(123.81±17.95) mmHg比(104.92±14.25) mmHg]、舒張壓[(88.31±10.28) mm-Hg比(72.24±8.45) mmHg],24h平均收縮壓變異度[(11.62±1.34) mmHg比(7.34±0.97) mmHg]、舒張壓變異度[(9.47±1.18) mmHg比(5.13±0.72) mmHg],QT間期[(385.1±50.4) ms比(342.7±48.5) ms]、校正QT間期[(362.7±50.2) ms比(321.8±45.1) ms]、QT間期離散度[(34.1±5.1) ms比(22.5±3.7) ms]均明顯降低(P<0.05或<0.01);室性心律失常分級明顯優于氨氯地平組(P<0.05)。結論:對于高血壓併髮心律失常病人西拉普利治療較氨氯地平降低血壓,QT間期離散度和改善室性心律失常的療效更好。
목적:연구서랍보리여안록지평대원발성고혈압환자QT간기리산도여심률실상적료효。방법:2011년3월~2014년3월아원수치적120례원발성고혈압합병실성심률실상적환자피납입연구대상,수궤균분위서랍보리조화안록지평조,량조균접수상규강압치료,비교량조적혈압、QT간기이급심률실상정황。결과:여안록지평조비교,서랍보리조환자적24h평균수축압[(123.81±17.95) mmHg비(104.92±14.25) mmHg]、서장압[(88.31±10.28) mm-Hg비(72.24±8.45) mmHg],24h평균수축압변이도[(11.62±1.34) mmHg비(7.34±0.97) mmHg]、서장압변이도[(9.47±1.18) mmHg비(5.13±0.72) mmHg],QT간기[(385.1±50.4) ms비(342.7±48.5) ms]、교정QT간기[(362.7±50.2) ms비(321.8±45.1) ms]、QT간기리산도[(34.1±5.1) ms비(22.5±3.7) ms]균명현강저(P<0.05혹<0.01);실성심률실상분급명현우우안록지평조(P<0.05)。결론:대우고혈압병발심률실상병인서랍보리치료교안록지평강저혈압,QT간기리산도화개선실성심률실상적료효경호。
Objective:To study therapeutic effect of cilazapril and amlodipine on QT interval dispersion and arrhyth-mia in patients with essential hypertension (EH) .Methods:A total of 120 EH patients complicated with ventricular arrhythmia in our hospital from Mar 2011 to Mar 2014 were enrolled ,randomly and equally divided into cilazapril group and amlodipine group ,the two groups all received routine antihypertensive therapy .Blood pressure ,QT in-terval and arrhythmias were compared between two groups .Results:Compared with amlodipine group ,there were significant reductions in 24h mean systolic blood pressure [24hSBP ,(123.81 ± 17.95) mmHg vs .(104.92 ± 14.25) mmHg] ,24h mean diastolic blood pressure [24hDBP ,(88.31 ± 10.28) mmHg vs .(72.24 ± 8.45) mmHg] ,24hSBP variability [ (11.62 ± 1.34) mmHg vs .(7.34 ± 0.97) mmHg] ,24hDBP variability [ (9.47 ± 1.18) mmHg vs .(5.13 ± 0.72) mmHg] ,QT interval [ (385.1 ± 50.4) ms vs .(342.7 ± 48.5) ms] ,corrected QT interval [ (362.7 ± 50.2) ms vs .(321.8 ± 45.1) ms] and QT interval dispersion [ (34.1 ± 5.1) ms vs .(22.5 ± 3.7) ms] in cilazapril group , P<0.05 or <0.01;ventricular arrhythmia class in cilazapril group was significantly better than that of amlodipine group , P<0. 05. Conclusion:Therapeutic effect of cilazapril is more helpful to reduce blood pressure ,QT interval dispersion and improve ventricular arrhythmia than amlodipine in EH patients complicated with arrhythmia .